Sunday, March 20, 2016 7:18:01 AM
Zusammenfassung: Vitae Pharmaceuticals Inc Outperform
Unternehmen:
Vitae Pharmaceuticals Inc Analyst:
Wedbush Morgan Securities Inc. Kursziel:
23,00 $
Rating jetzt:
Outperform Kurs*:
6,25 € Abst. Kursziel*:
268,12%
Rating update:
reiterated Kurs aktuell:
7,19 $ Abst. Kursziel aktuell:
219,89%
Analyst Name::
- KGV*:
-
* Zum Zeitpunkt der Analyse
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM